Lucid Diagnostics (LUCD) Research & Development (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Research & Development came in at $5.0 million in Q1 2026, up 22.93% YoY from $4.1 million in Q1 2025, and up 174.78% on a QoQ basis from -$6.7 million in Q4 2025.
Lucid Diagnostics (LUCD) Research & Development (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Research & Development data on file, last reported at $5.0 million in Q1 2026.
- Quarterly Research & Development rose 22.93% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $840000.0 (down 95.59% YoY) and the FY2025 annual result came in at $5.7 million, down 65.51% from the prior year.
- Research & Development improved to $5.0 million in Q1 2026, from -$6.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $11.9 million in Q4 2024 to a low of -$6.7 million in Q4 2025.
- A 5-year average of $3.3 million and a median of $2.9 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 1004.87% — and 2025, when it slumped 156.1%.
- Tracing LUCD's Research & Development over 5 years: stood at $5.0 million in 2022, then soared by 120.83% to $11.1 million in 2023, then increased by 7.71% to $11.9 million in 2024, then tumbled by 156.1% to -$6.7 million in 2025, then soared by 174.78% to $5.0 million in 2026.
- The last three Research & Development figures came in at $5.0 million (Q1 2026), -$6.7 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Lucid Diagnostics | 176.75 Mn | 143.35 Mn | 55,000.00 | 5.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.78 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | -6.69 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 11.92 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 11.07 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 4.03 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 5.01 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Mar 31, 2022 | 2.88 Mn |
| Dec 31, 2021 | -554,000.00 |
| Sep 30, 2021 | 2.19 Mn |